ScripIn the week that Merck & Co’s competing respiratory syncytial virus (RSV) antibody, clesrovimab, could get US approval , Sanofi and partner AstraZeneca are bringing forward the shipping of their
Generics BulletinAfter six years of litigation and on the eve of trial, AstraZeneca has agreed to pay a little over $50.9m to settle allegations in the US from a class of direct purchasers of its Seroquel XR (quetiapi
Pink SheetThe Maryland Prescription Drug Affordability Board (PDAB) does not automatically assume an upper payment limit is the go-to solution for drug affordability concerns, Executive Director Andrew York sai
ScripThe pharmaceutical industry in Europe has criticized the Council of the EU’s adoption of a package of legislative reforms for medicines, claiming that the continent’s innovation-unfriendly environment